Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Beacon Pharmaceuticals Revenue

Beacon Pharmaceuticals had revenue of 4.13B BDT in the quarter ending December 31, 2025, with 29.92% growth. This brings the company's revenue in the last twelve months to 14.78B, up 27.69% year-over-year. In the fiscal year ending June 30, 2025, Beacon Pharmaceuticals had annual revenue of 12.54B with 17.20% growth.

• Revenue (ttm): 14.78B
• Revenue Growth: +27.69%
• P/S Ratio: 1.57
• Revenue / Employee: 3.10M
• Employees: 4,162
• Market Cap: 23.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	12.54B	1.84B	17.20%
Jun 30, 2024	10.70B	2.19B	25.76%
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%
Jun 30, 2021	7.12B	1.53B	27.37%